Skip to content

4967.T

KOBAYASHI PHARMACEUTICAL CO.,LTD.

プライム · 化学 · 素材・化学 · JP

JPY 5,701.00
+0.39%
Ask drillr

Year over year

Reported trailing growth

Revenue
+0.1%
EBITDA
EBIT
-40.0%
EPS
-63.7%
Free cash flow
Operating cash flow

Forward estimates

Based on analyst estimates

Revenue
+3.2%
EBITDA
EPS
+187.2%

Three-year CAGR

Revenue
-0.1%
EBITDA
-10.5%
EBIT
-17.6%
Net income
-43.3%
EPS
-42.6%
Free cash flow
-10.4%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026